Physician profile
Scott B Mcgee
NPI 1306982871
$326.73
in general payments reported to CMS, 2019-2025
9 companies · $38.56 in 2025
The $38.56 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $125 · 2023: $125 · 2024: $37.57 · 2025: $38.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $110.69 | 2022-2023 | Relistor |
| Zimmer Biomet Holdings, INC. | $55.04 | 2022 | |
| Gilead Sciences, INC. | $35.44 | 2024-2025 | Trodelvy |
| Bioventus LLC | $26.04 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.04 | 2025 | Entyvio |
| Scilex Pharmaceuticals INC. | $21.03 | 2022 | |
| Biocryst US Sales Co., LLC | $20.96 | 2023 | Orladeyo |
| Boston Scientific Corporation | $18.65 | 2024 | Na |
| Averitas Pharma INC. | $16.84 | 2023 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Mcgee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.